|Articles|February 10, 2012
Podcast: Key Value Considerations for Growing BioPharm Product Pipeline
BioPharm International interviews Tarja Mottram, CEO of Action for Results, about a paradigm shift in how we measure and provide evidence for the impact of a product on healthcare outcomes. Posted Feb. 2012.
Advertisement
In part II of this BioPharm International interview, Tarja Mottram, CEO of
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
4
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
5
